Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Engulfing Bearish 15 69 Jan 29, 2025 12:15 ...

follow in the chart below. A complete list of Pfizer-sponsored accepted abstracts is available here. *TALZENNA in combination with XTANDI was approved by the U.S. Food and Drug Administration (FDA ...

A new study has found a combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet provides higher rates of type 2 diabetes remission compared to just calorie restriction alone.

New drugs like Carvykti ... At present, Spravato is approved in combination with an oral antidepressant to treat adults with TRD and depressive symptoms in adults with major depressive disorder ...

Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...

Remarkably, this approach achieves drug loadings of up to 98%, a dramatic improvement over traditional methods. By using a combination of computer models and laboratory tests, new drug/peptide ...